Welcome to our dedicated page for Flowserve SEC filings (Ticker: FLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Flowserve Corporation (NYSE: FLS) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Flowserve, a New York corporation listed on the New York Stock Exchange, uses current reports on Form 8-K and other filings to communicate material events related to its fluid motion and flow control business, which includes engineered pumps, valves, seals and flow management services.
In its Form 8-K filings, Flowserve reports a range of topics, such as results of operations and financial condition, leadership and board changes, and significant transactions. For example, the company has filed 8-Ks announcing quarterly financial results, including bookings, sales, margins and adjusted earnings per share, as well as updates on its guidance. Other 8-Ks describe the appointment or departure of certain officers, changes in board composition and related compensatory arrangements.
Flowserve’s filings also document strategic corporate actions. The company filed an 8-K detailing the mutual termination of a merger agreement with Chart Industries, Inc., including the receipt of a cash termination fee and reimbursement of expenses. Additional 8-Ks describe the entry into, and completion of, a transaction to divest BW/IP – New Mexico, Inc., the subsidiary holding its legacy asbestos liabilities and related insurance assets, and explain how those liabilities and assets are removed from its consolidated balance sheet.
Investors can use these filings to understand Flowserve’s exposure to risks and uncertainties, as the company includes extensive forward-looking statements and risk factor summaries in its 8-K disclosures. These sections discuss issues such as supply chain disruptions, dependence on energy, chemical and power generation markets, international regulatory risks, litigation, foreign currency exposure, environmental obligations and information technology and cybersecurity considerations.
On Stock Titan, AI-powered tools can help interpret complex Flowserve filings by summarizing key points from Forms 8-K and highlighting material developments in areas like capital allocation, acquisitions and divestitures, leadership changes and risk disclosures. Real-time updates from EDGAR, combined with AI-generated overviews, allow users to quickly see how new filings may affect their view of Flowserve’s operations and financial profile.
Flowserve Corp. President & CEO, who is also a director, reported exercising stock options and selling shares of the company’s common stock. On 12/02/2025, he exercised a stock option for 114,943 shares at an exercise price of $48.63 per share, increasing his holdings. That same day, he sold 114,943 shares at a weighted average price of $70.54 per share, plus additional sales of 95,223 shares at a weighted average price of $70.39 and 2,517 shares at a weighted average price of $70.92, all in multiple transactions within stated price ranges. After these transactions, he reported owning 346,630 shares of Flowserve common stock directly.
Flowserve Corporation investor plans to sell restricted shares under Rule 144. The notice covers a proposed sale of 212,683 shares of Flowserve common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $14,989,472.25 based on the figures provided. The issuer reports 127,115,509 shares of common stock outstanding, which provides context for the size of the planned sale.
The securities to be sold were acquired through restricted stock vesting on several dates in February 2024 and through the exercise of an option originally granted on May 4, 2017, with the option exercise dated December 2, 2025 and paid in cash. By signing the notice, the selling holder represents that they are not aware of any material adverse nonpublic information about Flowserve’s current or prospective operations and acknowledges that intentional misstatements or omissions can constitute federal criminal violations.
Flowserve Corp (FLS) director reported a change in ownership due to a charitable gift. On November 24, 2025, the reporting person made a charitable gift of 600 shares of Flowserve common stock, with no shares sold.
After this gift, the reporting person directly beneficially owns 22,396 shares of Flowserve common stock. The transaction was reported on a Form 4 as a gift, indicating it was not a market sale or purchase.
D1 Capital Partners L.P. and Daniel Sundheim filed a Schedule 13G reporting a passive stake in Flowserve Corporation. The filing lists 7,479,351 shares beneficially owned with shared voting and dispositive power over 7,479,351 shares and sole power over 0 shares. This represents 5.7% of Flowserve’s common stock, calculated against 130,782,241 shares outstanding as of July 21, 2025.
The investment is certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control. The filing notes the investment vehicle has the right to receive dividends and sale proceeds related to the reported shares.
Flowserve Corp (FLS) reported a director compensation transaction. On 11/13/2025, the reporting person acquired 530 units of phantom stock, each economically equivalent to one share of common stock, under the company’s deferred compensation plan. The phantom stock is payable in common shares upon termination of board service.
Following the transaction, the reporting person held 36,202 derivative securities directly. The filing lists a reference price of $69.27 per unit for the phantom stock entry.
Flowserve (FLS) reported a director transaction on 11/13/2025: the director acquired 435 shares of phantom stock (transaction code A) at $69.27 per unit under the company’s deferred compensation plan.
Each phantom share is economically equivalent to one share of common stock and is payable in common stock upon the director’s termination of board service. After this transaction, the director directly beneficially owns 18,500 derivative securities.
Flowserve Corp (FLS) director reported the acquisition of 435 shares of phantom stock on November 13, 2025 on a Form 4. Each phantom stock unit is the economic equivalent of one common share and reflects deferred director compensation.
The filing states these units become payable in common stock upon the director’s termination of board service. Following the transaction, the director beneficially owned 10,888 derivative securities, held directly. The filing lists a price of $69.27 for the phantom stock entry.
Flowserve (FLS) reported a routine insider compensation update. A director acquired 87 shares of phantom stock on 11/13/2025, coded as A for an acquisition. Each phantom stock unit is economically equivalent to one share of common stock and reflects deferred director compensation under the company’s plan. The filing lists an indicative price of $69.27 and shows 33,124 derivative securities beneficially owned following the transaction. These phantom stock units become payable in common stock upon the director’s termination of board service.
Flowserve (FLS) disclosed an insider transaction on Form 4. On 11/11/2025, the company’s officer (President, FPD) sold 1,609 shares of common stock at $69.51 (Transaction Code S). After this sale, the insider beneficially owns 15,116 shares, held directly.
Flowserve (FLS): A Form 144 notice discloses a proposed sale of 1,609 shares of common stock, with an aggregate market value of $111,841.59. The shares were acquired on 02/17/2025 via restricted stock vesting from the issuer as compensation.
The filing lists Fidelity Brokerage Services LLC as broker and the NYSE as the exchange, with an approximate sale date of 11/11/2025. Shares outstanding were 127,115,509. This is a routine notice of a potential secondary sale by a shareholder under Rule 144.